regulatory approval

News

BridgeBio gets EU nod for ATTR cardiomyopathy drug

BridgeBio and Bayer are poised to challenge Pfizer's Vyndaqel in the EU after acoramidis gets a green light for ATTR cardiomyopathy.

News

FDA clears new antibiotic for superbug infections

AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.

News

Graphic representation of an implant into an eyeball

FDA expands label for Roche's eye disease implant Susvimo

The renaissance of Roche's refillable ophthalmic implant Susvimo has continued with FDA approval for use in patients with diabetic macular oedema.

News

Boost to Enhertu's prospects as FDA clears Roche diagnostic

Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.

News

Vertex bags FDA okay for its non-opioid pain drug

Vertex gets FDA approval for its non-opioid pain drug suzetrigine, the first new class of pain medicine in the US in more than 20 years.

News

Ozempic is first GLP-1 drug FDA-approved for kidney disease

Novo Nordisk's Ozempic has become the first drug in the GLP-1 class to be cleared to prevent worsening kidney disease in type 2 diabetics.

BridgeBio gets EU nod for ATTR cardiomyopathy drug

FDA clears new antibiotic for superbug infections

FDA expands label for Roche's eye disease implant Susvimo

Boost to Enhertu's prospects as FDA clears Roche diagnostic

Vertex bags FDA okay for its non-opioid pain drug

Ozempic is first GLP-1 drug FDA-approved for kidney disease

Are Makary's priority review vouchers about to be canned?

Securing your ROI: Turning post-acquisition integration into...

regulatory approval

Editor's Picks